Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

University of Brasilia clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Brazil register with University of Brasilia as lead sponsor. Synced 15 Nov 2026
6Current trials
4Recruiting now
0Drugs in these trials
1Trial register
At a glance

University of Brasilia is the lead sponsor of 6 current clinical trials in our Brazil register. 4 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Cutaneous Leishmaniasis.

ClinicalTrials.gov trials by status

  • Recruiting467%
  • Not yet open117%
  • Active, closed117%

Trials by phase

  • Not applicable583%
  • Observational117%
01

Clinical trials sponsored by University of Brasilia

6 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
High-Frequency Ultrasound Monitoring of Cutaneous Leishmaniasis During Treatment
NCT07934446 · ClinicalTrials.gov ↗ · Cutaneous Leishmaniasis
Observational Recruiting 2025-01 Brazil
Immediate Effects of Neuromuscular Electrical Stimulation on Pain and Function in Achilles Tendon Disorders
NCT07453485 · ClinicalTrials.gov ↗ · Achilles Tendinopathy (AT), Achilles Tendon Rupture
Not applicable Recruiting 2026-01 Brazil
Continuous Radiofrequency in Hip Osteoarthritis Pain: A Randomized Clinical Trial.
NCT06221709 · ClinicalTrials.gov ↗ · Hip Osteoarthritis, Hip Pain Chronic
Not applicable Recruiting 2024-02 Brazil
Accuracy of the Polymerase Chain Reaction of Ulnar Perineural Subcutaneous Aspirate Guided by Ultrasound for the Diagnosis and Monitoring of Leprosy Cure
NCT07515989 · ClinicalTrials.gov ↗ · Leprosy, Leprosy Neuropathy, Leprosy, Multibacillary
Not applicable Recruiting 2026-01 Brazil
Combined Versus Multicomponent Training in People With Chronic Kidney Disease Stages 3a and 3b
NCT07901621 · ClinicalTrials.gov ↗ · Chronic Kidney Disease Stage 3A, Chronic Kidney Disease Stage 3B, Chronic Kidney Disease, Non-dialysis
Not applicable Not yet open 2027-05 Brazil
Trial-based Economic Evaluation of a Mobile Health Intervention for Individuals With Chronic Non-specific Low Back Pain
NCT06651099 · ClinicalTrials.gov ↗ · Low Back Pain
Not applicable Active, closed 2025-11 Brazil

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in University of Brasilia trials

13 conditions
Cutaneous Leishmaniasis1Achilles Tendinopathy (AT)1Achilles Tendon Rupture1Chronic Kidney Disease Stage 3A1Chronic Kidney Disease Stage 3B1Chronic Kidney Disease, Non-dialysis1Low Back Pain1Hip Osteoarthritis1Hip Pain Chronic1Leprosy1Leprosy Neuropathy1Leprosy, Multibacillary1Leprosy--Patients1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Brazil64

A trial with sites in more than one country appears in each of those registers.

04

Questions about University of Brasilia trials

How many clinical trials does University of Brasilia sponsor?

University of Brasilia is the lead sponsor of 6 current trials on ClinicalTrials.gov in our Brazil register, as of the registry sync on 15 November 2026. Completed and withdrawn studies are not counted.

Are University of Brasilia trials recruiting?

Yes. 4 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 15 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.